You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

CLINICAL TRIALS PROFILE FOR FARXIGA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for farxiga

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02235298 ↗	Dapagliflozin Effects on Epicardial Fat	Completed	AstraZeneca	Phase 4	2015-09-01	The purpose of this research study is to learn about the effect of Dapagliflozin (Farxiga) on the fat of the heart.
NCT02235298 ↗	Dapagliflozin Effects on Epicardial Fat	Completed	University of Miami	Phase 4	2015-09-01	The purpose of this research study is to learn about the effect of Dapagliflozin (Farxiga) on the fat of the heart.
NCT02371187 ↗	Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?	Completed	AstraZeneca	Phase 2	2015-06-01	Exercise is frequently prescribed as a favorable lifestyle intervention to prevent/reverse type 2 diabetes. It is also prescribed in addition to concurrent pharmacological treatment, such as metformin. Recent data (animal and human) suggest that metformin may attenuate the favorable benefits of exercise training. In light of the physiological mechanism of Dapagliflozin (sodium-glucose co-transporter 2 (SGLT2) inhibition), one might speculate that rather than inhibit, it will augment the favorable adaptations to exercise training.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for farxiga

Condition Name

Chart
Table

Condition Name for farxiga
Intervention	Trials
Diabetes Mellitus, Type 2	12
Weight Loss	2
Cystinuria	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for farxiga
Intervention	Trials
Diabetes Mellitus	22
Diabetes Mellitus, Type 2	21
Diabetes Mellitus, Type 1	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for farxiga

Trials by Country

Map
Table

Trials by Country for farxiga
Location	Trials
United States	108
Brazil	16
India	7
Canada	4
Netherlands	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for farxiga
Location	Trials
Texas	16
New York	10
California	8
Florida	6
Missouri	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for farxiga

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for farxiga
Clinical Trial Phase	Trials
Phase 4	23
Phase 3	6
Phase 2	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for farxiga
Clinical Trial Phase	Trials
Completed	17
Recruiting	13
Unknown status	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for farxiga

Sponsor Name

Chart
Table

Sponsor Name for farxiga
Sponsor	Trials
AstraZeneca	15
The University of Texas Health Science Center at San Antonio	10
University at Buffalo	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for farxiga
Sponsor	Trials
Other	66
Industry	20
NIH	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.